Genzyme, Repligen deal

GENZ agreed to purchase RGEN's recombinant Protein A technology and diagnostics reagents business and the manufacturing facilities of RGEN's Allegro Biologics business unit for an undisclosed amount of cash.

GENZ's pharmaceutical group will market bulk Protein A, which is used to purify monoclonal antibodies, for therapeutic processing uses. The diagnostics product group will sell Protein A and the recombinant Protein A ELISA kit for laboratory research. ...